182 related articles for article (PubMed ID: 29076126)
1. Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.
Manso R; Sánchez-Beato M; González-Rincón J; Gómez S; Rojo F; Mollejo M; García-Cosio M; Menárguez J; Piris MA; Rodríguez-Pinilla SM
Br J Haematol; 2018 Nov; 183(3):497-501. PubMed ID: 29076126
[No Abstract] [Full Text] [Related]
2. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
3. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
[No Abstract] [Full Text] [Related]
4. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
5. Tools and methods for studying the Drosophila JAK/STAT pathway.
Chen Q; Giedt M; Tang L; Harrison DA
Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
[TBL] [Abstract][Full Text] [Related]
6. Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.
Lee K; Evans MG; Yang L; Ng S; Snowden C; Khodadoust M; Brown RA; Trum NA; Querfeld C; Doan LT; Song J; Zhang H; Gru AA; Wood GS; Wada DA; Shanmugam V; Haun PL; Aster JC; Duncan LM; Guitart J; Weinstock DM; Nardi V; Choi J
Blood; 2021 Dec; 138(23):2435-2440. PubMed ID: 34432866
[TBL] [Abstract][Full Text] [Related]
7. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E; Ladewig E; Schiavoni G; Penson A; Fortini E; Pettirossi V; Wang Y; Rosseto A; Venanzi A; Vlasevska S; Pacini R; Piattoni S; Tabarrini A; Pucciarini A; Bigerna B; Santi A; Gianni AM; Viviani S; Cabras A; Ascani S; Crescenzi B; Mecucci C; Pasqualucci L; Rabadan R; Falini B
Blood; 2018 May; 131(22):2454-2465. PubMed ID: 29650799
[TBL] [Abstract][Full Text] [Related]
8. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
Venugopal S; Bar-Natan M; Mascarenhas JO
Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas.
Nicolae A; Xi L; Pham TH; Pham TA; Navarro W; Meeker HG; Pittaluga S; Jaffe ES; Raffeld M
Leukemia; 2016 Nov; 30(11):2245-2247. PubMed ID: 27389054
[No Abstract] [Full Text] [Related]
10. A robust in vivo model for B cell precursor acute lymphoblastic leukemia.
Fry TJ; Aplan PD
J Clin Invest; 2015 Sep; 125(9):3427-9. PubMed ID: 26301807
[TBL] [Abstract][Full Text] [Related]
11. Analysis of JAK-STAT signaling pathway genes and their microRNAs in the intestinal mucosa of genetically disparate chicken lines induced with necrotic enteritis.
Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
Vet Immunol Immunopathol; 2017 May; 187():1-9. PubMed ID: 28494922
[TBL] [Abstract][Full Text] [Related]
12. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
Pike KA; Tremblay ML
Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
[TBL] [Abstract][Full Text] [Related]
13. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
[TBL] [Abstract][Full Text] [Related]
14. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
Chaimowitz NS; Forbes LR
Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
[TBL] [Abstract][Full Text] [Related]
15. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
16. SnapShot: Jak-STAT Signaling II.
Villarino AV; Gadina M; O'Shea JJ; Kanno Y
Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic analysis of patients with mutations in the JAK/STAT signaling pathway in adult acute lymphoblastic leukemia].
Fan WJ; Xu TT; Guo JJ; Li YF; Jiang ZX
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):594-597. PubMed ID: 34455748
[No Abstract] [Full Text] [Related]
18. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus.
Kawasaki M; Fujishiro M; Yamaguchi A; Nozawa K; Kaneko H; Takasaki Y; Takamori K; Ogawa H; Sekigawa I
Lupus; 2011 Oct; 20(12):1231-9. PubMed ID: 21980035
[TBL] [Abstract][Full Text] [Related]
19. HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
de Bock CE; Demeyer S; Degryse S; Verbeke D; Sweron B; Gielen O; Vandepoel R; Vicente C; Vanden Bempt M; Dagklis A; Geerdens E; Bornschein S; Gijsbers R; Soulier J; Meijerink JP; Heinäniemi M; Teppo S; Bouvy-Liivrand M; Lohi O; Radaelli E; Cools J
Cancer Discov; 2018 May; 8(5):616-631. PubMed ID: 29496663
[TBL] [Abstract][Full Text] [Related]
20. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
